You have 9 free searches left this month | for more free features.

omega-N-Methylarginine

Showing 26 - 50 of 8,561

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Insulin Resistance Trial in Scottsdale (Insulin, NG-monomethyl-L-arginine)

Completed
  • Obesity
  • Insulin Resistance
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 1, 2021

Chronic Pain Following Thermal Burn Injury Trial in Chapel Hill (Omega-3 fatty acids (fish oil), Vitamin D3 (cholecalciferol),

Terminated
  • Chronic Pain Following Thermal Burn Injury
  • Omega-3 fatty acids (fish oil)
  • +3 more
  • Chapel Hill, North Carolina
    University Of North Carolina
Jul 23, 2021

Diabetes Trial in Oxford (Aspirin, Omega-3 Ethyl Esters, Placebo Aspirin)

Active, not recruiting
  • Diabetes Mellitus
  • Oxford, United Kingdom
    Clinical Trial Service Unit, NDPH, University of Oxford
Jun 17, 2021

Cognitive Impairment, Depression Trial in Guanzhou (Experimental group of n-pufas improving cognitive formula, General fish oil

Recruiting
  • Cognitive Impairment
  • Depression
  • Experimental group of n-pufas improving cognitive formula
  • +2 more
  • Guanzhou, Guangdong, China
    Guangzhou Brain Hospital (Guangzhou Huiai Hospital)
Mar 15, 2021

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)

Active, not recruiting
  • Stage IA Breast Cancer
  • +6 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 14, 2022

Arthralgia, Breast Tumors Trial in Duarte, Cleveland, Columbus (Omega-3 Fatty Acid, Placebo)

Recruiting
  • Arthralgia
  • Breast Neoplasms
  • Omega-3 Fatty Acid
  • Placebo
  • Duarte, California
  • +2 more
Jan 14, 2021

Alcohol Use Disorder, Severe Trial (Active Comparator: Omega-3, Placebo Comparator: olive oil)

Not yet recruiting
  • Alcohol Use Disorder, Severe
  • Active Comparator: Omega-3
  • Placebo Comparator: olive oil
  • (no location specified)
Jun 1, 2023

Psychosis Trial in Canada, United States (Omega-3 Long Chain Fatty Acid, Placebo)

Completed
  • Psychosis
  • Omega-3 Long Chain Fatty Acid
  • Placebo
  • Los Angeles, California
  • +8 more
Feb 3, 2021

Non-Muscle Invasive Bladder Cancer Trial in Mansoura (n-3PUFAs Treatment, Placebo Treatment)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • n-3PUFAs Treatment
  • Placebo Treatment
  • Mansoura, Egypt
    Urology and Nephrology Center, Mansoura University
Dec 17, 2020

Obesity Trial in Guadalajara (n-3 supplementation group, Placebo group)

Completed
  • Obesity
  • n-3 supplementation group
  • Placebo group
  • Guadalajara, Jaliscco, Mexico
  • +1 more
May 25, 2021

Coronary Artery Disease Trial in Ankara (Omega-3 fatty acid supplementation)

Completed
  • Coronary Artery Disease
  • Omega-3 fatty acid supplementation
  • Ankara, Turkey
    Gazi University Training and Research Hospital
Dec 14, 2022

Arthritis, Rheumatoid Trial in Rancagua (Placebo, Omega-3, Aerobic exercise)

Active, not recruiting
  • Arthritis, Rheumatoid
  • Placebo
  • +2 more
  • Rancagua, Libertador Bernardo O'Higgins, Chile
    Universidad de O'Higgins
Jul 11, 2023

Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma

Completed
  • Plasma Omega-3 Status
    • Glasgow, United Kingdom
    • +4 more
    Jul 4, 2021

    Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions Trial in Canada (DHA-rich algal oil, Placebo)

    Active, not recruiting
    • Bronchopulmonary Dysplasia
    • +2 more
    • DHA-rich algal oil
    • Placebo
    • Calgary, Alberta, Canada
    • +15 more
    Jul 9, 2021

    Eating Disorder Trial in Hamilton (Omega-3 Fatty Acid Supplement)

    Completed
    • Eating Disorder
    • Omega-3 Fatty Acid Supplement
    • Hamilton, Ontario, Canada
      McMaster Children's Hospital
    Dec 18, 2020

    Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Los Angeles (behavioral, dietary

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • +3 more
    • behavioral dietary intervention
    • +2 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Apr 4, 2022

    Sarcopenia Trial in Cordoba (omega-3, Standard)

    Recruiting
    • Sarcopenia
    • omega-3
    • Standard
    • Cordoba, Spain
      IMIBIC
    Aug 23, 2023

    Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)

    Recruiting
    • Hypertriglyceridemia
    • DHA-NAT
    • Placebo
    • Hellerup, Denmark
      Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
    Jul 11, 2023

    Age Related Cognitive Decline, Alzheimer's Disease, Vascular Dementia Trial in Portland (Omega 3 PUFA, Placebo)

    Active, not recruiting
    • Age Related Cognitive Decline
    • +4 more
    • Omega 3 PUFA
    • Placebo
    • Portland, Oregon
      Oregon Health & Science University
    Sep 2, 2020

    Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia Trial in Tbilisi (Omega device)

    Recruiting
    • Lower Urinary Tract Symptoms
    • Benign Prostatic Hyperplasia
    • Omega device
    • Tbilisi, Georgia
    • +1 more
    Mar 8, 2023

    Depression Trial in Guangzhou (omega-3, )

    Enrolling by invitation
    • Depression
    • omega-3
    • placebo
    • Guangzhou, Guangdong, China
      Nanfang Hospital
    Jul 11, 2023

    Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)

    Not yet recruiting
    • Cardiovascular Risk
    • Plant Omega
    • Dietary therapy only
    • Petaling Jaya, Selangor, Malaysia
      Beacon Hospital Sdn Bhd
    May 21, 2023

    Hypertriglyceridemia Trial in Tehran (Control, Omega-3 supplementation, Chia seed)

    Not yet recruiting
    • Hypertriglyceridemia
    • Control
    • +2 more
    • Tehran, Iran, Islamic Republic of
      Clinical Nutrition Research Unit, National Nutrition and Food Te
    Sep 3, 2023

    Autism Spectrum Disorders, Hyperactivity Trial in Multiple Locations (Omega-3 Fatty Acids, Placebo)

    Completed
    • Autism Spectrum Disorders
    • Hyperactivity
    • Omega-3 Fatty Acids
    • Placebo
    • Multiple Locations, Maryland
      This study is open to continental USA
    Aug 17, 2020

    Metastatic Triple Negative Breast Cancer Trial in Houston (L-NMMA, Docetaxel, Amlodipine)

    Completed
    • Metastatic Triple Negative Breast Cancer
    • Houston, Texas
      Houston Methodist Hospital
    Oct 12, 2021